Commonweal Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques.
AI & Machine LearningBiotechDeep TechCambridge, US
Donald A. Bergstrom(Executive Officer)inSanjiv K. Patel(Director, President and Chief Executive Officer)inSekar Kathiresan(Director)Douglas S. Ingram(Director)Mark Murcko(Director)Laura Shawver(Director)
Co-investorsEcoR1 CapitalForesite CapitalNat TurnerNextech InvestSoftBank Vision FundCurie.Bio+2 more
Grid develops uncrewed, long-range cargo aircraft ("Lifter") that carry heavy payloads over thousands of miles, operated as a distributed, autonomous mesh network managed by small ground teams.
Defense TechLogistics & Supply ChainRoboticsPalo Alto, US
Alex Kroll(Executive Officer)Chinmay Patel(Co-founder & CTO)inArthur Paul Dubois Taine(Founder / Aerospace Engineering Leader)Arthur Dubois(Co-founder & CEO)inBrandon Florian(Co-founder & CCO)in
Co-investorsAlumni VenturesBison VenturesCalibrate VenturesGeodesic CapitalUbiquity VenturesVirginia Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.














